| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 8, 478-489, Copyright © 1994 by Endocrine Society
ARTICLES |
A Lytras and PA Cattini
Department of Physiology, University of Manitoba, Winnipeg, Canada.
The human chorionic somatomammotropin genes (hCS-A and -B) are expressed at high levels in the syncytiotrophoblast during pregnancy. A 22-base-pair (bp) transcriptional enhancer factor-1 (TEF-1) element in a 1022-bp fragment of the hCS-B 3'-flanking DNA (nucleotides 1-1022) was shown to be important for efficient promoter activity in placental cells. However, the TEF-1 site used alone does not contain all of the information required for the complete enhancer activity seen with the 1022-bp fragment. A 241-bp region of the 1022-bp fragment (nucleotides 1-241) maintains full enhancer activity in placental cells. Interactions between placental nuclear factors and sequences distinct from the TEF-1 element (nucleotides 117-139) were identified by gel mobility shift assay using the up-stream region corresponding to nucleotides 1-80. Interaction between these factors and the TEF-1 element was indicated by competition of the 1-80 bp region for complex formation by a TEF-1 site. We mutated sequences within the 1-80 bp region of the 241-bp enhancer fragment and assessed the enhancer function of wild-type and modified 241-bp fragments. We identified a sequence (DF-1 site) upstream of the TEF-1 site which is required for hCS-B enhancer function. DF-1 derepresses a repressor mechanism present in the 241-bp fragment that inhibits TEF-1 activity. A component of this repressor mechanism (RF-1 site) is present in the 1-80 bp region adjacent to the DF-1 site. Gel mobility shift competition analysis shows that the RF-1 and DF-1 sites participate in the formation of a common complex or compete for common protein factors in a tissue- specific manner.
This article has been cited by other articles:
![]() |
L. D. Norquay, X. Yang, Y. Jin, K. A. Detillieux, and P. A. Cattini Hepatocyte Nuclear Factor-3{alpha} Binding at P Sequences of the Human Growth Hormone Locus Is Associated with Pituitary Repressor Function Mol. Endocrinol., March 1, 2006; 20(3): 598 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jin, L. D. Norquay, X. Yang, S. Gregoire, and P. A. Cattini Binding of AP-2 and ETS-Domain Family Members Is Associated with Enhancer Activity in the Hypersensitive Site III Region of the Human Growth Hormone/Chorionic Somatomammotropin Locus Mol. Endocrinol., March 1, 2004; 18(3): 574 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Limesand, K. M. Jeckel, and R. V. Anthony Pur{alpha}, a Single-Stranded Deoxyribonucleic Acid Binding Protein, Augments Placental Lactogen Gene Transcription Mol. Endocrinol., February 1, 2004; 18(2): 447 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jin, F. Sheikh, K. A. Detillieux, and P. A. Cattini Role for Early Growth Response-1 Protein in alpha 1-Adrenergic Stimulation of Fibroblast Growth Factor-2 Promoter Activity in Cardiac Myocytes Mol. Pharmacol., May 1, 2000; 57(5): 984 - 990. [Abstract] [Full Text] |
||||
![]() |
Y. Jin, R. M. Surabhi, A. Fresnoza, A. Lytras, and P. A. Cattini A Role for A/T-Rich Sequences and Pit-1/GHF-1 in a Distal Enhancer Located in the Human Growth Hormone Locus Control Region with Preferential Pituitary Activity in Culture and Transgenic Mice Mol. Endocrinol., August 1, 1999; 13(8): 1249 - 1266. [Abstract] [Full Text] |
||||
![]() |
S.-W. Jiang, K. Wu, and N. L. Eberhardt Human Placental TEF-5 Transactivates the Human Chorionic Somatomammotropin Gene Enhancer Mol. Endocrinol., June 1, 1999; 13(6): 879 - 889. [Abstract] [Full Text] |
||||
![]() |
S.-W. Jiang, M. A. Trujillo, and N. L. Eberhardt Human Chorionic Somatomammotropin Enhancer Function Is Mediated by Cooperative Binding of TEF-1 and CSEF-1 to Multiple, Low-Affinity Binding Sites Mol. Endocrinol., August 1, 1997; 11(9): 1223 - 1232. [Abstract] [Full Text] |
||||
![]() |
S.-W. Jiang and N. L. Eberhardt The Human Chorionic Somatomammotropin Enhancers Form a Composite Silencer in Pituitary Cells in Vitro Mol. Endocrinol., August 1, 1997; 11(9): 1233 - 1244. [Abstract] [Full Text] |
||||
![]() |
P. Jacquemin, J. A. Martial, and I. Davidson Human TEF-5 Is Preferentially Expressed in Placenta and Binds to Multiple Functional Elements of the Human Chorionic Somatomammotropin-B Gene Enhancer J. Biol. Chem., May 16, 1997; 272(20): 12928 - 12937. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jacquemin, J.-J. Hwang, J. A. Martial, P. Dolle, and I. Davidson A Novel Family of Developmentally Regulated Mammalian Transcription Factors Containing the TEA/ATTS DNA Binding Domain J. Biol. Chem., September 6, 1996; 271(36): 21775 - 21785. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-W. Jiang and N. L. Eberhardt Involvement of a Protein Distinct from Transcription Enhancer Factor-1 (TEF-1) in Mediating Human Chorionic Somatomammotropin Gene Enhancer Function through the GT-IIC Enhanson in Choriocarcinoma and COS Cells J. Biol. Chem., June 9, 1995; 270(23): 13906 - 13915. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |